Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ramezan Ali Ataee has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Real- Time - RT PCR Study of Extract of Ammi visnaga on Pseudomonas aeruginosa Exo A and Exo S Genes Expression

    by Negin Bahmanpoor, Seyed Mohammad Mahdi Hamdi, RamezanAli Ataee

    Background and Aim: Pseudomonas aeruginosa exotoxins are responsible for pathogenicity and antibiotic resistant. The aim of this study was to investigate the effects of the Ammi. visnaga (A. visnaga) extract on the P. aeruginosa exotoxin A and S genes expression. Materials and Methods: Antibacterial effects of the A. visnaga ethanolic extract were performed using ...


  • Open Access

    Real-time RT PCR Evaluation of the Xylitol Effect on the Expression of Streptococcus pneumoniae cpsB,cpsD and psaA Genes

    by Ali Asgari, RamezanAli Ataee, Ali Mehrabi Tavana, Reza Mirnejad, Mahdi Ghorbanalizdgan

    Background and Objective: The major pneumococcal pathogenesis factor is the capsular polysaccharide. the production of polysaccharide is regulated by cpsB and cpsD genes. Thus, every agent that induce or inhibition of expression of these genes probably increased pathogenesis of bacteria, intracellular survival and vis versa. The aim of this study was ...

  • Open Access

    Rheumatoid arthritis mediator CD18 expression by Staphylococcus aureus superantigen C in rats

    by Mahsa Banaei, Gholam Hosein Alishiri, Ramezan Ali Ataee, Ardeshir Hesampoor Mahalati

    Background and Objectives: Microbial superantigens have been reported in the blood and synovial fluid of rheumatoid arthritis patients, raising the question of whether the presence of these superantigens could provoke the induction of inflam- matory biomarkers expression or not. The purpose of this study was to examine the Staphylococcus aureus superantigen C on CD18 expression. Materials and Methods: The superantigen C was purified by ultrafiltration. Immunoblotting was performed using a specific antibody. Also, 50 micrograms of superantigens (toxin) were injected intraperitoneally and intra-articularly into separate rat groups. Blood was collected and RNA extracted. Then, the cDNA was synthesized. The expression of CD18 marker was evaluated using RT-real-time PCR, and the results were descriptively analyzed. Results: The results of this study revealed that 50 μg of toxin, injected intra-articularly and intraperitoneally, showed the surplus expression of the marker CD18 in the blood of rats after 20 days. By this method, the expression of the marker CD18 was significantly different between rats that received the superantigen intra-articularly and intraperitoneally (2.10; 2.3 and 3.3 folds) and the controls (P≤ 0.05). Conclusion: The results indicated that the presence of Staphylococcal of superantigen C in the body of rats has enhanced the expression of the CD18 inflammatory marker more than 3 times. This valuable finding is an introduction to further research and could provide new methods to prevent and control inflammatory diseases, including rheumatoid arthritis.


  • Open Access

    Effect of Xylitol on the Growth and Survival of Streptococcus pneumoniae

    by Ramezan Ali Ataee, Ali Asgari, Mahdi Ghorbanalizadegan, Ali Mehrabi Tavana

    Jundishapur Journal of Microbiology


  • Open Access

    Real Time RT RCR Detection of mRNA Encoding Enterotoxin B Staphylococcus aureus in Synovial Fluid of Patients with Rheumatoid Arthritis

    by Ramezan Ali Ataee, Vahide Zare, Alishiri Gholam Hossein, Davood Esmaeili, Mahdi Tata

    Staphylococcal enterotoxins (superantigens) in Rheumatoid arthritis patients are considered. Nevertheless, there is unclear where is the origin of these superantigens in the SF of RA patients. This study aimed to assess mRNA encoding Staphylococcal enterotoxin B gene in Synovial fluid of the patients with RA. This experimental study, eighty Synovial fluids of patients with RA was assayed. The mRNA extraction carried out. Based on Staphylococcal enterotoxin B gene specific primers for RT Real Time PCR designed. Then, cDNA was synthesized and amplification by SYBR®Green Real Time RCR was down. The S. aureus strain ATCC 14458 as positive control was used. The results analyzed descriptively. The results indicated, using specific primers and probe for enterotoxin B could amplify the related cDNA gene. SYBR®Green Real Time RT RCR method has been outline that 38 cases (47.5%) were showed. In fact, the reverse transcriptase convert mRNA to cDNA for partially encoding staphylococcal enterotoxin B (superantigen) gene. In comparison positive and negative control, the results descriptively analyzed.The results showed, Real Time RT RCR were able to detect and characterized the mRNA producing enterotoxin B gene in Synovial fluid of 47.5% of the RA patients. Despite the finding may be discussed the direct role of enterotoxin B as a classic superantigen in the pathophysiology of RA disease. It may demonstrate the causative of disease and facilitate the rapid detection. However, more research is needed this finding could change the perspective approach treatment of the RA diseases.

  • Open Access

    Assay of Blood and Synovial Fluid of Patients With Rheumatoid Arthritis for Staphylococcus aureus Enterotoxin D: Absence of Bacteria But Presence of Its Toxin

    by Ramezan Ali Ataee, Reyhane Kashefi, Gholam Hossein Alishiri, Davoud Esmaieli

    Background: Rheumatoid arthritis (RA) is the most common chronic inflammatory disease. The staphylococcal superantigens are considered as the causative agent of RA disease. Objectives: This study aimed to assess the presence of staphylococcal enterotoxin D in synovial fluid and blood of patients with RA. Patients and Methods: A total of 120 blood and SF samples of patients with RA were studied. Bacterial culture, primer pairs design, polymerase chain reaction (PCR), and enzyme-linked immunosorbent assay (ELISA) methods have been used to assess of the staphylococcal enterotoxin D. The data were analyzed through descriptive statistics. Results: During this study and after sequential subcultures, only 5 bacterial strains were isolated. The results of PCR showed the presence of staphylococcal enterotoxin D gene in almost 50% of SF and also in 48.4% of blood samples of patients with RA. Similarly, the ELISA method detected staphylococcal enterotoxin D in 36.16% of SF and in 33.33% of blood of patients with RA. Conclusions: The result of this study showed that a high percentage of patients with RA have shown staphylococcal enterotoxin D (superantigen D) or entD gene in SF and in blood. However, the origin of this superantigen was not clarified and no Staphylococcus aureus enterotoxin D producer was isolated. This finding indicates other role of this superantigen besides its intoxication. Therefore, staphylococcal enterotoxin D as a biomarker may provide a good model for the diagnosis and treatment of patients with RA. Keywords: Enterotoxin D; Staphylococcal; Superantigens; Arthritis; Rheumatoid; Polymerase Chain Reaction; Enzyme-Linked Immunosorbent Assay; Synovial Fluid


    • 1 June 2015
      • Vol. 18  (6) , 345-50

    Simultaneous Detection of Mycoplasma pneumoniae, Mycoplasma hominis and Mycoplasma arthritidis in Synovial Fluid of Patients with Rheumatoid Arthritis by Multiplex PCR.

    by Ramezan Ali Ataee, Reza Golmohammadi, GholamHosein Alishiri, Reza Mirnejad, Ali Najafi, Davood Esmaeili, Nematollah Jonaidi Jafari

    It has been recognized that infectious agents, such as different bacteria and viruses, may play a role in the developing of rheumatoid arthritis (RA). Recently, the mycoplasma species has been implicated in the pathogenesis of RA. The aim of this study was to design a multiplex PCR for rapid and simultaneous detection of Mycoplasma pneumoniae, Mycoplasma hominis, and Mycoplasma arthritidis in the synovial fluid of patients with rheumatoid arthritis (RA). A total of 131 synovial fluid (SF) samples from patients with RA were assayed. Mycoplasma pneumoniae (ATCC: 29342), M. hominis (native strain), and the synthetic complete genome of M. arthritidis mitogen (MAM) superantigen were used as controls. All SF samples were subjected to DNA extraction separately and multiplex PCR was performed. The PCR products were confirmed by sequencing. The designed multiplex PCR was able to detect M. pneumoniae, M. hominis, and M. arthritidis in the SF of patients with RA with a frequency of 30 (22.9%), 23 (17.5%) and 13 (9.9%), respectively. In this study, the overall detection of the Mycoplasma species in RA patients was 53.4%; thus, we recommend the application of multiplex PCR assays when searching for a specific anti mycoplasma treatment for RA patients.


  • Open Access

    Determination of vancomycin minimum inhibitory concentration for ceftazidime resistant Streptococcus pneumoniaein Iran

    by Ramezan Ali Ataee, Samira Habibian, Ali Mehrabi-Tavana, Zyanab Ahmadi, Nematollah Jonaidi, Mahmood Salesi

    In the context of growing health concerns over antibiotic resistance, the evaluation of the minimum inhibitory concentration (MIC) of vancomycin for Streptococcus pneumoniae (S. pneumoniae) strains resistant to ceftazidime becomes important for guiding health policy makers. The aim of this study was to determine vancomycin MIC of ceftazidime resistant S. pneumoniae strains. Fifty identified serotypes of ceftazidime resistant S. pneumoniae strains were included in the study. The vancomycin MIC of the above mentioned bacteria was determined based on the 0.5 McFarland standards, by using a microdilution broth and the Etest method. The results showed that out of 50 ceftazidime resistant strains of S. pneumoniae, 46 strains (92%) have shown a vancomycin MIC ≤0.19 − 0.1.5 μg/ml and only four strains (8%) have shown a vancomycin MIC equal to 1.5 μg/ml and the related maximum zone of inhibition was of 10 millimeter diameters. The results of this investigation point out the emergence of S. pneumoniae strains with a vancomycin MIC ≥1.5 μg/ml, which were resistant to ceftazidime. This finding uncovers a major health concern: a vancomycin MIC higher than 1.5 μg/ml and maximum zone of inhibition of only 10 millimeter. These findings represent an important warning for health authorities globally, concerning the treatment of patients, as the occurrence of S. pneumoniae strains with decreased vancomycin susceptibility has been demonstrated.


  • Open Access

    Molecular Screening of Staphylococcal Enterotoxin Type P Encoding Gene From Clinical Isolates

    by Ramezan Ali Ataee, Mojtaba Hedaiatich, Rahim Mansuor Khanshan, Mohammad Hosein Ataee

    Molecular Screening of Staphylococcal Enterotoxin Type P Encoding Gene From Clinical Isolates - Jundishapur Journal of Microbiology - - Kowsar